FDA approves drug for treating postpartum depression
|CTVnews 19 Mar 2019 at 15:40|
TRENTON, N.J. -- The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth.
The agency on Tuesday approved Sage Therapeutics Zulresso (ZUHL -ress-oh), an IV drug given over 2 1/2 days.
In a company-funded study of new mothers with moderate or severe postpartum depression, half the women given Zulresso had depression end within 2 1/2 days, about double the rate of those in a comparison group given dummy treatments.
Postpartum depression affects about 400,000 American women a year. It s often treated with antidepressants, though they can take several weeks to help and don t always work.